The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.

Published

Journal Article

Peroxisome proliferator-activated receptor gamma (PPARgamma) is a transcription factor in the steroid nuclear receptor superfamily. Ligand activation of PPARgamma is associated with differentiation and an inhibition of proliferation in normal and malignant cells, including adipocytes, monocytes, and tumor cells in colon, prostate, and breast cancers. The current studies were undertaken to assess both the expression and functional activity of PPARgamma in cultured normal human mammary epithelial cells (HMECs) and tissue samples. Analyses by northern hybridization, immunoblotting, and immunohistochemistry demonstrate PPARgamma gene expression in HMECs and breast tissue specimens. DNA binding and transactivation assays indicate the presence of functionally active PPARgamma in HMECs. Treatment with PPARgamma selective ligands, 15-deoxy-delta-(12,14)-prostaglandin J2 (15dPGJ2) and ciglitazone, inhibits the growth of HMECs in a dose-dependent manner. This growth inhibition is associated with alterations in cell cycle progression and the induction of apoptosis.

Full Text

Cited Authors

  • Yee, LD; Guo, Y; Bradbury, J; Suster, S; Clinton, SK; Seewaldt, VL

Published Date

  • March 2003

Published In

Volume / Issue

  • 78 / 2

Start / End Page

  • 179 - 192

PubMed ID

  • 12725418

Pubmed Central ID

  • 12725418

Electronic International Standard Serial Number (EISSN)

  • 1573-7217

International Standard Serial Number (ISSN)

  • 0167-6806

Digital Object Identifier (DOI)

  • 10.1023/a:1022978608125

Language

  • eng